Abstract
Photodynamic therapy (PDT) and photothermal therapy (PTT) are two kinds of methodologies that can be applied to the treatment of cancer. They own some advantages over the existing strategies including chemo- and radiotherapy but at the same time, are also facing big challenges. During the past decades, great efforts have been devoted to overcome the bottlenecks and to push these two newly-emerging methodologies to practical applications. One of the big achievements is the utilization of nanocarbon materials in PDT and PTT. Nanocarbon materials include zero-dimensional fullerene, one-dimensional carbon nanotubes (CNTs), and two-dimensional graphene. Upon illumination, fullerene can generate reactive oxygen species (ROS) through both Type I and Type II photochemistry, which allows it a good candidate for PDT. CNTs and graphene generate significant amount of heat upon excitation with near-infrared light, which makes them suitable for PTT. In this review, recent developments of the application of nanocarbon materials in PDT and PTT are briefly summarized and discussed.
Keywords: Carbon nanotubes, fullerene, graphene, photodynamic therapy, photothermal therapy, tumor.
Pharmaceutical Nanotechnology
Title:Nanocarbon Materials for Photodynamic Therapy and Photothermal Therapy
Volume: 2 Issue: 2
Author(s): Qian Li, Hong Ruan and Hongguang Li
Affiliation:
Keywords: Carbon nanotubes, fullerene, graphene, photodynamic therapy, photothermal therapy, tumor.
Abstract: Photodynamic therapy (PDT) and photothermal therapy (PTT) are two kinds of methodologies that can be applied to the treatment of cancer. They own some advantages over the existing strategies including chemo- and radiotherapy but at the same time, are also facing big challenges. During the past decades, great efforts have been devoted to overcome the bottlenecks and to push these two newly-emerging methodologies to practical applications. One of the big achievements is the utilization of nanocarbon materials in PDT and PTT. Nanocarbon materials include zero-dimensional fullerene, one-dimensional carbon nanotubes (CNTs), and two-dimensional graphene. Upon illumination, fullerene can generate reactive oxygen species (ROS) through both Type I and Type II photochemistry, which allows it a good candidate for PDT. CNTs and graphene generate significant amount of heat upon excitation with near-infrared light, which makes them suitable for PTT. In this review, recent developments of the application of nanocarbon materials in PDT and PTT are briefly summarized and discussed.
Export Options
About this article
Cite this article as:
Li Qian, Ruan Hong and Li Hongguang, Nanocarbon Materials for Photodynamic Therapy and Photothermal Therapy, Pharmaceutical Nanotechnology 2014; 2 (2) . https://dx.doi.org/10.2174/2211738502666140929211831
| DOI https://dx.doi.org/10.2174/2211738502666140929211831 |
Print ISSN 2211-7385 |
| Publisher Name Bentham Science Publisher |
Online ISSN 2211-7393 |
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Synthesis, Cytotoxicity and Antioxidant Activity of New Analogs of RC-121 Synthetic Derivatives of Somatostatin
Anti-Cancer Agents in Medicinal Chemistry Recent Research Progress in Natural Bioactive Constituents against Lipid Metabolic Diseases
Current Topics in Medicinal Chemistry Emerging Targets to Relieve Fat Stress-Induced Liver Diseases: UDCA, Tocotrienol, ω-3 PUFAs, and IgY Targeted NPC1L1 Cholesterol Transporter
Current Pharmaceutical Design MEMS and Microfluidics for Diagnostics Devices
Current Pharmaceutical Biotechnology Dasabuvir: A Non-Nucleoside Inhibitor of NS5B for the Treatment of Hepatitis C Virus Infection
Reviews on Recent Clinical Trials Green Tea from the Far East to the Drug Store: Focus on the Beneficial Cardiovascular Effects
Current Pharmaceutical Design The Therapeutic Value and Molecular Mechanisms of lncRNA FENDRR in Human Cancer
Current Pharmaceutical Design Chaperoning the Cancer: The Proteostatic Functions of the Heat Shock Proteins in Cancer
Recent Patents on Anti-Cancer Drug Discovery Pharmacophore Modeling, Synthesis, Scaffold Hopping and Biological β- Hematin Inhibition Interaction Studies for Anti-malaria Compounds
Current Topics in Medicinal Chemistry Advances in Nanomedicine Towards Clinical Application in Oncology and Immunology
Current Pharmaceutical Biotechnology Difluorinated Curcumin: A Promising Curcumin Analogue with Improved Anti-Tumor Activity and Pharmacokinetic Profile
Current Pharmaceutical Design Amygdalin from Apricot Kernels Induces Apoptosis and Causes Cell Cycle Arrest in Cancer Cells: An Updated Review
Anti-Cancer Agents in Medicinal Chemistry Editorial: Metal ions in cause, progression, treatment and diagnosis of genetic disorders, metabolic diseases and cancer
Current Drug Metabolism Role of ZEB Family Members in Proliferation, Metastasis, and Chemoresistance of Prostate Cancer Cells: Revealing Signaling Networks
Current Cancer Drug Targets Review of the Role of Metabolic Factors in Determining the Post-surgical Adhesion and its Therapeutic Implications, with a Focus on Extracellular Matrix and Oxidative Stress
Current Molecular Pharmacology Recent Advances in Pegylated Interferon Antiviral Therapy of Chronic Hepatitis C
Anti-Infective Agents in Medicinal Chemistry Spectrum of Radiopharmaceuticals in Nuclear Oncology
Current Cancer Drug Targets Can Systems Biology Understand Pathway Activation? Gene Expression Signatures as Surrogate Markers for Understanding the Complexity of Pathway Activation
Current Genomics Palladium-Catalyzed Oxyarylation, Azaarylation and α-Arylation Reactions in the Synthesis of Bioactive Isoflavonoid Analogues
Current Organic Synthesis Pharmacological Evaluation of Novel 1,2,4-triazine Derivatives Containing Thiazole Ring against Hepatocellular Carcinoma
Current Bioactive Compounds





